Making headway — a role for CGRP in post-traumatic headache
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Loading...
Although common, post-traumatic headache remains poorly understood and poorly treated. New data have implicated calcitonin gene-related peptide and the trigeminovascular system in this
disorder, opening up new avenues for research into its pathophysiology and treatment.
D.D.M. has received honoraria and research or travel grants from Amgen, Allergan, Biogen, Genesis Pharma, Eli Lily, Novartis, Merz, Roche, Specifar, Teva. M.A.M. declares no competing
interests.
Anyone you share the following link with will be able to read this content: